-logo-1200x675.png?v=20220915161652&w=240&h=240&zc=2){kind=logo}
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Consensus Rating of “Buy” by Analysts
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) has been given a consensus recommendation of “Buy” by the six research firms that are currently covering the firm, Marketbeat.com reports. Six research analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have updated their coverage on the stock […]
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) has been given a consensus recommendation of “Buy” by the six research firms that are currently covering the firm, Marketbeat.com reports. Six research analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have updated their coverage on the stock […]
